Trial Outcomes & Findings for A Randomised Cross-over Study With Two 1-piece Urostomy Bags. (NCT NCT00765388)

NCT ID: NCT00765388

Last Updated: 2014-03-11

Results Overview

Subjects were asked which of the tested products they preferred; SenSura or Moderma.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

27 participants

Primary outcome timeframe

4 weeks

Results posted on

2014-03-11

Participant Flow

Subjects where recruited by 6 stoma care sites in UK

No pre-assignment details

Participant milestones

Participant milestones
Measure
Hollister Uro First, Then SenSura Uro
SenSura Uro (test product) and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
SenSura Uro First, Then Hollister Uro
SenSura Uro (test product) and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Period 1
STARTED
16
11
Period 1
COMPLETED
15
6
Period 1
NOT COMPLETED
1
5
Period 2
STARTED
15
6
Period 2
COMPLETED
15
6
Period 2
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Hollister Uro First, Then SenSura Uro
SenSura Uro (test product) and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
SenSura Uro First, Then Hollister Uro
SenSura Uro (test product) and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Period 1
Lack of Efficacy
1
2
Period 1
Lost to Follow-up
0
1
Period 1
Herpes Zoster
0
1
Period 1
Hip operation
0
1

Baseline Characteristics

A Randomised Cross-over Study With Two 1-piece Urostomy Bags.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Entire Study Population
n=27 Participants
Includes groups randomized to receive SenSura Uro first and Hollister Uro first
Age, Continuous
61.6 years
STANDARD_DEVIATION 11.5 • n=5 Participants
Sex: Female, Male
Female
9 Participants
n=5 Participants
Sex: Female, Male
Male
18 Participants
n=5 Participants
Region of Enrollment
United Kingdom
27 participants
n=5 Participants

PRIMARY outcome

Timeframe: 4 weeks

Subjects were asked which of the tested products they preferred; SenSura or Moderma.

Outcome measures

Outcome measures
Measure
SenSura Uro
n=27 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=27 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Preference of Sensura vs Moderma
45 percentage of prefering the product
43 percentage of prefering the product

SECONDARY outcome

Timeframe: 4 weeks

Population: Intention to treat (ITT)

Evaluation of immediate adhesion after each period

Outcome measures

Outcome measures
Measure
SenSura Uro
n=21 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=20 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Immediate Adhesion
Very poor
1 Participants
1 Participants
Immediate Adhesion
Poor
1 Participants
4 Participants
Immediate Adhesion
Reasonable
8 Participants
4 Participants
Immediate Adhesion
Good
7 Participants
6 Participants
Immediate Adhesion
Very good
4 Participants
5 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

How easy/difficult it was to remove the bag

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Removal of the Bag
Very easy
5 Participants
5 Participants
Removal of the Bag
Easy
12 Participants
11 Participants
Removal of the Bag
Reasonable
5 Participants
7 Participants
Removal of the Bag
Difficult
0 Participants
0 Participants
Removal of the Bag
Very difficult
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

Evaluation of the adhesion of the base plate around the stoma during use

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Adhesion of the Bag During Use
Very poor
2 Participants
3 Participants
Adhesion of the Bag During Use
Poor
5 Participants
5 Participants
Adhesion of the Bag During Use
Reasonable
7 Participants
5 Participants
Adhesion of the Bag During Use
Good
3 Participants
6 Participants
Adhesion of the Bag During Use
Very good
5 Participants
4 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

Evaluation of the adhesives ability to absorb perspiration from the skin

Outcome measures

Outcome measures
Measure
SenSura Uro
n=21 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Adhesives Ability to Absorb Perspiration
Very poor
1 Participants
0 Participants
Adhesives Ability to Absorb Perspiration
Poor
2 Participants
4 Participants
Adhesives Ability to Absorb Perspiration
Reasonable
8 Participants
7 Participants
Adhesives Ability to Absorb Perspiration
Good
6 Participants
9 Participants
Adhesives Ability to Absorb Perspiration
Very good
4 Participants
2 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

Evaluation of the ability of the bag to conform with the patients movements (flexibility)

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Flexibility of the Product
Very poor
1 Participants
1 Participants
Flexibility of the Product
Poor
0 Participants
4 Participants
Flexibility of the Product
Reasonable
8 Participants
5 Participants
Flexibility of the Product
Good
8 Participants
10 Participants
Flexibility of the Product
Very good
5 Participants
3 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

Evaluates the patients awareness of the presence of the product during use.

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Awareness of the Presence of the Product
Very much
0 Participants
2 Participants
Awareness of the Presence of the Product
Much
1 Participants
3 Participants
Awareness of the Presence of the Product
Some
8 Participants
5 Participants
Awareness of the Presence of the Product
A little
11 Participants
10 Participants
Awareness of the Presence of the Product
Not at all
2 Participants
3 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

The patients feeling of security with the bag during the day

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Feeling of Security During the Day
Very poor
3 Participants
4 Participants
Feeling of Security During the Day
Poor
3 Participants
4 Participants
Feeling of Security During the Day
Reasonable
5 Participants
5 Participants
Feeling of Security During the Day
Good
7 Participants
7 Participants
Feeling of Security During the Day
Very good
4 Participants
3 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

The patients feeling of security with the product during the night

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Feeling of Security During the Night
Very poor
3 Participants
3 Participants
Feeling of Security During the Night
Poor
4 Participants
4 Participants
Feeling of Security During the Night
Reasonable
3 Participants
6 Participants
Feeling of Security During the Night
Good
6 Participants
7 Participants
Feeling of Security During the Night
Very good
6 Participants
3 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

The patient was asked whether he/she noticed any splashinh sounds during use

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Problems With Splashing Sounds During Use
Very much
0 Participants
1 Participants
Problems With Splashing Sounds During Use
Much
0 Participants
0 Participants
Problems With Splashing Sounds During Use
Some
3 Participants
3 Participants
Problems With Splashing Sounds During Use
A little
4 Participants
4 Participants
Problems With Splashing Sounds During Use
Not at all
15 Participants
15 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

The patient was asked if he/she noticed whether the bag twisted during night

Outcome measures

Outcome measures
Measure
SenSura Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=23 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Bag Twisting During Night
Yes
4 Participants
13 Participants
Bag Twisting During Night
No
18 Participants
10 Participants

SECONDARY outcome

Timeframe: 4 weeks

Population: ITT population

The patient was asked whether he/she experienced changes in the skin condition after testing the blue/red product

Outcome measures

Outcome measures
Measure
SenSura Uro
n=21 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Hollister Uro
n=22 Participants
SenSura Uro (test product)and Hollister Uro (comparator) are CE-marked, non-sterile, 1-piece urostomy devices.
Changes in Skin Compared to Before Study
No, it is the same
17 Participants
19 Participants
Changes in Skin Compared to Before Study
Yes, it is better
0 Participants
1 Participants
Changes in Skin Compared to Before Study
Yes, it is worse
4 Participants
2 Participants

Adverse Events

Hollister Uro

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

SenSura Uro

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Seema Suchdev Wrisberg

Coloplast A/S

Phone: +4549113519

Results disclosure agreements

  • Principal investigator is a sponsor employee Investigator may publish the Inventions subject to the prior written consent of Sponsor. The Investigator shall submit the manuscript to Sponsor for approval, provided however that the Investigator will submit the manuscript at least thirty (30) days before disclosure for such proposed publication. If Sponsor wishes to file patent applications on Inventions Sponsor is allowed to delay the publication upon to a maximum period of 6 months since he above-mentioned submission.
  • Publication restrictions are in place

Restriction type: OTHER